Literature DB >> 17627381

A new 6-bp SOX-3 polyalanine tract deletion does not segregate with mental retardation.

Michele Salemi1, Corrado Romano, Letizia Ragusa, Giuseppa Di Vita, Roberto Salluzzo, Ileana Oteri, Maria Luisa Trovato, Carmelo Romano, Filippo Caraci, Ferdinando Nicoletti, Paolo Bosco.   

Abstract

SOX-3 is a transcription factor expressed throughout the developing central nervous system and is involved in maintenance of pluripotency in self-renewing stem cells, specification events, lineage progression, and terminal differentiation. An association between growth hormone deficiency, mental retardation, and Sox-3 mutations in humans was previously reported. The occurrence of abnormalities affecting the polyalanine tract of the Sox-3 gene was determined in a group of 77 unrelated mentally retarded patients without a definite genetic diagnosis and in 84 control subjects. A new SOX-3 polyalanine tract deletion was identified in a mentally impaired boy, in his mother (homozygous), and in 2 healthy brothers of the proband. This new mutation does not segregate with mental retardation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627381     DOI: 10.1089/gte.2006.0510

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  2 in total

1.  SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Down's syndrome subjects with undescended testes.

Authors:  Michele Salemi; Corrado Romano; Concetta Barone; Francesco Calí; Filippo Caraci; Carmelo Romano; Cataldo Scavuzzo; Francesco Scillato; Maria Grazia Salluzzo; Maria Piccione; Manuela Martines; Giovanni Corsello; Ferdinando Nicoletti; Paolo Bosco
Journal:  J Genet       Date:  2009-04       Impact factor: 1.166

2.  Case Report: A Novel Point Mutation of SOX3 in a Subject With Growth Hormone Deficiency, Hypogonadotrophic Hypogonadism, and Borderline Intellectual Disability.

Authors:  Jing Li; Yuxia Zhong; Tao Guo; Yerong Yu; Jianwei Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-28       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.